This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Merrill, R. A. Search for Related Content PubMed PubMed Citation Articles by Merrill, R. A. Related Collections Legal/Regulatory Issues Pharmaceuticals Research And Technology

Health Affairs, Vol 13, Issue 3, 47-69
Copyright © 1994 by Project HOPE

Journal Article

Regulation of drugs and devices: an evolution

The U.S. Food and Drug Administration's (FDA's) drug approval process has evolved from a system in which a drug could lawfully be marketed unless the FDA were able to prove that the manufacturer knew that the drug would not work for the conditions for which it was promoted to one in which drug-makers require advance approval from the agency for almost every important step in testing, production, and marketing. The more modern system for regulating medical devices is the product of amendments to the federal Food, Drug, and Cosmetic Act in 1976. In those amendments, Congress sought to create a framework for control of device technology that would also facilitate innovation. This paper suggests that, notwithstanding this aspiration, both external pressures and internal practices are inexorably bringing device regulation closer to the "drug model."

                      What's this?

This article has been cited by other articles:

				G. J. Bazzoli, L. Dynan, L. R. Burns, and C. Yap Two Decades of Organizational Change in Health Care: What Have we Learned? Med Care Res Rev, September 1, 2004; 61(3): 247 - 331. [Abstract] [PDF]

				T. S. Jost, D. Hughes, L. Griffiths, and J. McHale The British Health Care Reforms, the American Health Care Revolution, and Purchaser/Provider Contracts Journal of Health Politics Policy and Law, December 1, 1995; 20(4): 885 - 908. [Abstract] [PDF]